Katherine Ann Rubino
Patent Attorney
Caldwell Intellectual Property Law
katie@caldwellip.com
March 17, 2019
CAFC Affirms IPR Dismissal for Lack of Standing and Mootness By: Katie Rubino On February 7th, 2019 the Court of Appeals for the Federal Circuit […]
March 3, 2019
CAFC Upholds Unpatentability of Diagnostic Method Claims By: Katie Rubino On February 6th, 2019 the U.S. Court of Appeals for the Federal Circuit (CAFC) in Athena […]
February 18, 2019
First Cannabis Patent to Survive IPR Challenge In Part By: Katie Rubino On January 3rd, 2019 the Patent Trial and Appeal Board (PTAB) issued a final […]
February 5, 2019
CAFC Rules USPTO Exceeded Its Authority Adjusting Patent Term By: Katie Rubino Recently on January 27th, 2019 the U.S. Court of Appeals for the Federal Circuit […]
January 27, 2019
Buyer Beware: Secret Sales May Result in Subsequent Patent Invalidity By: Katie Rubino Recently on January 22, 2019, the Supreme Court affirmed the Federal Circuit’s […]
January 18, 2019
Final Decision Reached in Initial Insulin IPR Proceeding By: Katie Rubino On December 12th, 2018 the U.S. Patent and Trademark Appeal Board (PTAB) […]
January 11, 2019
How to Allocate Resources to Intellectual Property as a Start-Up By: Katie Rubino When a venture is first getting off the ground, there […]
December 10, 2018
A review of new patent strategies developing around protein kinase inhibitors by patent attorney Katie Rubino.
November 18, 2018
Legal Review: The United States-Mexico-Canada Agreement compared with NAFTA as it relates to IP, with a special focus on how it could affect chemical and biological pharmaceutical products.
November 5, 2018
Court Case Review: University of California v. Broad Institute, Inc. #2017-1907 by Patent Attorney Katie Rubino. Case involves CRISPR-Cas9 patents held by Harvard and MIT.